Why should you ask your doctor about VALSTAR®?
VALSTAR® is an FDA-approved treatment option for your carcinoma in situ (CIS) bladder cancer that failed previous therapies and if you’re not a candidate for surgery.
Find your reasons
Only about 1 in 5 patients no longer had CIS bladder cancer 6 months after treatment with VALSTAR®. Waiting to have your bladder taken out could lead to the spread of bladder cancer and even death. In a study of VALSTAR®, 10 out of the 90 patients developed deeply-invasive bladder cancer; 4 of them died with metastatic bladder cancer and 6 had progressed to a deeply-invasive disease by the time they had surgery to remove their bladder. You should talk with your doctor about the risks of waiting for surgery to have your bladder taken out when you have CIS bladder cancer.